Boni L - Search Results

1

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: does cisplatin versus carboplatin make a difference?

Tiseo M, Boni L, Ardizzoni A. Tiseo M, et al. Among authors: boni l. J Clin Oncol. 2005 Sep 1;23(25):6276-7; author reply 6277-8. doi: 10.1200/JCO.2005.02.0156. J Clin Oncol. 2005. PMID: 16135504 No abstract available.

2

Induction chemotherapy followed by concurrent standard radiotherapy and daily low-dose cisplatin in locally advanced non-small-cell lung cancer.

Ardizzoni A, Grossi F, Scolaro T, Giudici S, Foppiano F, Boni L, Tixi L, Cosso M, Mereu C, Ratto GB, Vitale V, Rosso R. Ardizzoni A, et al. Among authors: boni l. Br J Cancer. 1999 Sep;81(2):310-5. doi: 10.1038/sj.bjc.6990693. Br J Cancer. 1999. PMID: 10496358 Free PMC article. Clinical Trial.

3

Ambamustine in the second-line treatment of patients with small-cell lung cancer: a phase II Fonicap study.

Ardizzoni A, Antonelli G, Ricci S, Frasci G, Rinaldi M, Boni L, Galletti P, Pennucci MC, Antonuzzo A, Gravina A, Galli L, Comella G, Conte PF, Salvati F, Rosso R. Ardizzoni A, et al. Among authors: boni l. Am J Clin Oncol. 2000 Feb;23(1):22-5. doi: 10.1097/00000421-200002000-00005. Am J Clin Oncol. 2000. PMID: 10683068 Clinical Trial.

4

Gemcitabine, Ifosfamide and Navelbine (GIN): activity and safety of a non-platinum-based triplet in advanced non-small-cell lung cancer (NSCLC).

Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C, Neumaier C, Conte PF, Rosso R; Italian Lung Cancer Task Force. Baldini E, et al. Among authors: boni l. Br J Cancer. 2001 Nov 16;85(10):1452-5. doi: 10.1054/bjoc.2001.2108. Br J Cancer. 2001. PMID: 11720427 Free PMC article. Clinical Trial.

5

Gemcitabine, ifosfamide and Navelbine (GIN): a platinum-free combination in advanced non-small-cell lung cancer (NSCLC).

Baldini E, Ardizzoni A, Prochilo T, Cafferata MA, Boni L, Tibaldi C. Baldini E, et al. Among authors: boni l. Cancer Chemother Pharmacol. 2002 May;49 Suppl 1:S25-8. doi: 10.1007/s00280-002-0449-z. Epub 2002 Apr 17. Cancer Chemother Pharmacol. 2002. PMID: 12042986 Review.

6

Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.

Grossi F, Loprevite M, Chiaramondia M, Ceppa P, Pera C, Ratto GB, Serrano J, Ferrara GB, Costa R, Boni L, Ardizzoni A. Grossi F, et al. Among authors: boni l. Eur J Cancer. 2003 Jun;39(9):1242-50. doi: 10.1016/s0959-8049(03)00232-6. Eur J Cancer. 2003. PMID: 12763212

7

Platinum-etoposide chemotherapy in elderly patients with small-cell lung cancer: results of a randomized multicenter phase II study assessing attenuated-dose or full-dose with lenograstim prophylaxis--a Forza Operativa Nazionale Italiana Carcinoma Polmonare and Gruppo Studio Tumori Polmonari Veneto (FONICAP-GSTPV) study.

Ardizzoni A, Favaretto A, Boni L, Baldini E, Castiglioni F, Antonelli P, Pari F, Tibaldi C, Altieri AM, Barbera S, Cacciani G, Raimondi M, Tixi L, Stefani M, Monfardini S, Antilli A, Rosso R, Paccagnella A. Ardizzoni A, et al. Among authors: boni l. J Clin Oncol. 2005 Jan 20;23(3):569-75. doi: 10.1200/JCO.2005.11.140. J Clin Oncol. 2005. PMID: 15659503 Clinical Trial.

8

Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis.

Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, Radosavljevic D, Paccagnella A, Zatloukal P, Mazzanti P, Bisset D, Rosell R; CISCA (CISplatin versus CArboplatin) Meta-analysis Group. Ardizzoni A, et al. Among authors: boni l. J Natl Cancer Inst. 2007 Jun 6;99(11):847-57. doi: 10.1093/jnci/djk196. J Natl Cancer Inst. 2007. PMID: 17551145

9

Epidermal growth factor receptor intron-1 polymorphism predicts gefitinib outcome in advanced non-small cell lung cancer.

Tiseo M, Capelletti M, De Palma G, Franciosi V, Cavazzoni A, Mozzoni P, Alfieri RR, Goldoni M, Galetti M, Bortesi B, Bozzetti C, Loprevite M, Boni L, Camisa R, Rindi G, Petronini PG, Ardizzoni A. Tiseo M, et al. Among authors: boni l. J Thorac Oncol. 2008 Oct;3(10):1104-11. doi: 10.1097/JTO.0b013e3181861d67. J Thorac Oncol. 2008. PMID: 18827605 Free article.

10

Predictors of gefitinib outcomes in advanced non-small cell lung cancer (NSCLC): study of a comprehensive panel of molecular markers.

Tiseo M, Rossi G, Capelletti M, Sartori G, Spiritelli E, Marchioni A, Bozzetti C, De Palma G, Lagrasta C, Campanini N, Camisa R, Boni L, Franciosi V, Rindi G, Ardizzoni A. Tiseo M, et al. Among authors: boni l. Lung Cancer. 2010 Mar;67(3):355-60. doi: 10.1016/j.lungcan.2009.04.021. Epub 2009 May 26. Lung Cancer. 2010. PMID: 19473722

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

768 results

Search Page

Filters